# Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

> **NCT06289582** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** [F-18]DPA714 administration IV

## Key facts

- **NCT ID:** NCT06289582
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06289582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06289582, "Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06289582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*